The Comparative Safety and Effectiveness of Bivalirudin Versus Heparin Monotherapy in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

BACKGROUND: Dialysis patients are at a higher risk of bleeding after PCI; however, due to their exclusion from randomized clinical trials, the optimal antithrombotic regimen for this population remains unknown. We sought to evaluate the comparative safety and effectiveness of bivalirudin monotherapy...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Catheter Cardiovasc Interv
Hlavní autoři: Sukul, Devraj, Seth, Milan, Schreiber, Theodore, Khandelwal, Akshay, Cannon, Louis A., LaLonde, Thomas A., Gurm, Hitinder S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850212/
https://ncbi.nlm.nih.gov/pubmed/28303632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccd.27001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky